Path

Filing Period

Jan 1, 2011 to Dec 31, 2011

Signed

Nov 13, 2012

Return Version

2011v1.2

Gross Receipts

$299,740,142

Mission

Major Activities

Activity 2

Emerging and epidemic diseases:the burden of emerging and epidemic diseases-including malaria, hiv/aids, tuberculosis (tb), and influenza-falls most heavily on developing countries with the fewest resources to respond. Path works around the globe to help these countries strengthen prevention, diagnosis, and treatment; encourage healthy behaviors; and mobilize resources to control disease. To decrease malaria transmission, path partners with national programs to pioneer new control strategies. In 2011 the malaria control and evaluation partnership in africa, a program at path, worked closely with senegal's malaria control program to develop district-level plans and implement a transmission elimination strategy. In zambia, we helped train workers in advanced malaria surveillance methods in nearly 400 clinics across 17 districts. To reduce the burden of hiv, path worked in 2011 to enhance hiv awareness and prevention among at-risk groups, prevent mother-to-child transmission, strengthen care and treatment services, and integrate related health services. In india, for example, we helped prevent infections among vulnerable populations through education and treatment programs. In senegal, we educated and empowered women at high risk to negotiate condom use. And in zambia, we expanded voluntary counseling and testing services to increase treatment among serodiscordant couples. To prevent mother-to-child transmission, we expanded use of a new treatment protocol in zimbabwe and helped tens of thousands of expectant mothers in south africa receive important services to protect their babies from hiv. In the democratic republic of congo, ethiopia, and kenya, we built the capacity of local partners and communities to integrate services, strengthen health systems, and provide hiv testing and counseling. Path uses our long-standing expertise in gender and health to address gender-based constraints that contribute to hiv risk. In senegal, for example, path began work in 2011 to assess the impact of a community-based health and human rights program on levels of gender-based violence that can lead to hiv vulnerability.in 2011 we also addressed the need for better tb diagnosis, treatment, and care by providing technical assistance to strengthen health systems and collaborating with numerous countries to support implementation of the international stop tb strategy. In collaboration with the world health organization, we published a toolkit that helps countries strengthen strategies for detecting, treating, and monitoring multidrug-resistant tb.

Activity 3

Health technologies:path develops appropriately designed, affordable, and innovative technologies to address high-priority health problems in low-resource settings. Our interventions help improve immunization, nutrition, diagnosis, child survival, and maternal and reproductive health.in 2011 one of our largest technology-focused efforts was the safe water project, which worked to develop a variety of methods for the commercial production, marketing, and distribution of household water treatment and safe storage solutions in asia and africa. In addition, our technologies for health project focused on adapting, designing, developing, and advancing a range of technologies. These included neonatal resuscitators, chlorhexidine to reduce neonatal deaths from umbilical stump infections, and oxytocin for reducing deaths from postpartum hemorrhage.path also advanced point-of-care diagnostics for neglected tropical diseases, hiv and sexually transmitted infections, cervical cancer, and malaria. Our jet injector project focused on needle-free disposable syringes for administering vaccines, and in 2011 we completed user assessements of device prototypes in brazil, china, and india. In addition, path developed markets for our silcs diaphragm and woman's condom to offer new options in contraception and infection prevention.

Filer

EIN

91-1157127